跳至主要内容
临床试验/NCT04513613
NCT04513613撤回不适用

A Post-Market Registry for the Evaluation of the CorPath® GRX System Effectiveness in Peripheral Vascular Interventions

Corindus Inc.0 个研究点开始时间: 2022年1月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
Corindus Inc.
主要终点
Technical Success

研究概览

简要总结

This study will evaluate real-world performance of the CorPath GRX System in peripheral vascular interventions.

详细描述

This is a prospective, single-arm, open-label, multi-center registry of the CorPath GRX System to evaluate its real-world performance during peripheral vascular interventions.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years.
  • Subject has a clinical indication for Peripheral Vascular Intervention (PVI).
  • Subject is deemed appropriate for robotic-assisted PVI.
  • The subject has been informed of the nature of the study, agrees to its provisions and has provided written informed consent.
  • Individual monitoring of radiation dose, using the pocket dosimeter, was initiated at start of procedure.

排除标准

  • Failure/inability/unwillingness to provide informed consent.
  • The investigator determines the subject or the peripheral anatomy is not suitable for ro-botic-assisted PVI.
  • Women who are pregnant.

结局指标

主要结局

Technical Success

时间窗: Procedure

Successful completion of the robotic-assisted endovascular procedure absent any unplanned conversion to manual for guidewire or balloon/stent catheter inability to navigate vessel anatomy.

Clinical Success

时间窗: Within 24 hours of the procedure or hospital discharge, whichever occurs first.

\<30% residual stenosis in all CorPath System treated lesions at the completion of the interventional procedure in the absence of device-related serious adverse event (SAE).

Safety

时间窗: Within 24 hours of the procedure or hospital discharge, whichever occurs first.

A composite of intra- and peri-procedural events, including target vessel rupture, clinically significant perforation or dissection, and distal embolization.

次要结局

  • PVI Procedure Time(Procedure)
  • Operator Radiation Exposure(Procedure)
  • Staff Radiation Exposure(Procedure)
  • Robotic Time(Procedure)
  • Manual Time(Procedure)
  • Fluoroscopy Time(Procedure)
  • Patient Radiation Exposure(Procedure)
  • Contrast Fluid Volume(Procedure)

研究者

发起方
Corindus Inc.
申办方类型
Industry
责任方
Sponsor

相似试验